TY - JOUR AU - Johnstone, R. W. PY - 2002 DA - 2002// TI - Histone-deacetylase inhibitors: novel drugs for the treatment of cancer JO - Nat Rev Drug Discov VL - 1 UR - https://doi.org/10.1038/nrd772 DO - 10.1038/nrd772 ID - Johnstone2002 ER - TY - JOUR AU - Liu, T. AU - Kuljaca, S. AU - Tee, A. AU - Marshall, G. M. PY - 2006 DA - 2006// TI - Histone deacetylase inhibitors: multifunctional anticancer agents JO - Cancer Treat Rev VL - 32 UR - https://doi.org/10.1016/j.ctrv.2005.12.006 DO - 10.1016/j.ctrv.2005.12.006 ID - Liu2006 ER - TY - JOUR AU - Marks, P. AU - Rifkind, R. A. AU - Richon, V. M. AU - Breslow, R. AU - Miller, T. AU - Kelly, W. K. PY - 2001 DA - 2001// TI - Histone deacetylases and cancer: causes and therapies JO - Nat Rev Cancer VL - 1 UR - https://doi.org/10.1038/35106079 DO - 10.1038/35106079 ID - Marks2001 ER - TY - JOUR AU - Kelly, W. K. AU - Marks, P. A. PY - 2005 DA - 2005// TI - Drug insight: Histone deacetylase inhibitors--development of the new targeted anticancer agent suberoylanilide hydroxamic acid JO - Nat Clin Pract Oncol VL - 2 UR - https://doi.org/10.1038/ncponc0106 DO - 10.1038/ncponc0106 ID - Kelly2005 ER - TY - JOUR AU - Folkman, J. AU - Kalluri, R. PY - 2004 DA - 2004// TI - Cancer without disease JO - Nature VL - 427 UR - https://doi.org/10.1038/427787a DO - 10.1038/427787a ID - Folkman2004 ER - TY - JOUR AU - Bergers, G. AU - Benjamin, L. E. PY - 2003 DA - 2003// TI - Tumorigenesis and the angiogenic switch JO - Nat Rev Cancer VL - 3 UR - https://doi.org/10.1038/nrc1093 DO - 10.1038/nrc1093 ID - Bergers2003 ER - TY - JOUR AU - von Marschall, Z. AU - Scholz, A. AU - Cramer, T. AU - Schafer, G. AU - Schirner, M. AU - Oberg, K. AU - Wiedenmann, B. AU - Hocker, M. AU - Rosewicz, S. PY - 2003 DA - 2003// TI - Effects of interferon alpha on vascular endothelial growth factor gene transcription and tumor angiogenesis JO - J Natl Cancer Inst VL - 95 UR - https://doi.org/10.1093/jnci/95.6.437 DO - 10.1093/jnci/95.6.437 ID - von Marschall2003 ER - TY - JOUR AU - Tosato, G. PY - 2003 DA - 2003// TI - Interferon-alpha is implicated in the transcriptional regulation of vascular endothelial growth factor JO - J Natl Cancer Inst VL - 95 UR - https://doi.org/10.1093/jnci/95.6.420 DO - 10.1093/jnci/95.6.420 ID - Tosato2003 ER - TY - JOUR AU - Brouty-Boye, D. AU - Zetter, B. R. PY - 1980 DA - 1980// TI - Inhibition of cell motility by interferon JO - Science VL - 208 UR - https://doi.org/10.1126/science.6154315 DO - 10.1126/science.6154315 ID - Brouty-Boye1980 ER - TY - JOUR AU - Bjornsti, M. A. AU - Houghton, P. J. PY - 2004 DA - 2004// TI - The TOR pathway: a target for cancer therapy JO - Nat Rev Cancer VL - 4 UR - https://doi.org/10.1038/nrc1362 DO - 10.1038/nrc1362 ID - Bjornsti2004 ER - TY - JOUR AU - Cinatl, J. AU - Kotchetkov, R. AU - Blaheta, R. AU - Driever, P. H. AU - Vogel, J. U. AU - Cinatl, J. PY - 2002 DA - 2002// TI - Induction of differentiation and suppression of malignant phenotype of human neuroblastoma BE(2)-C cells by valproic acid: enhancement by combination with interferon-alpha JO - Int J Oncol VL - 20 ID - Cinatl2002 ER - TY - JOUR AU - Michaelis, M. AU - Suhan, T. AU - Cinatl, J. AU - Driever, P. H. AU - Cinatl, J. PY - 2004 DA - 2004// TI - Valproic acid and interferon-alpha synergistically inhibit neuroblastoma cell growth in vitro and in vivo JO - Int J Oncol VL - 25 ID - Michaelis2004 ER - TY - JOUR AU - Richon, V. M. AU - Sandhoff, T. W. AU - Rifkind, R. A. AU - Marks, P. A. PY - 2000 DA - 2000// TI - Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation JO - Proc Natl Acad Sci U S A VL - 97 UR - https://doi.org/10.1073/pnas.180316197 DO - 10.1073/pnas.180316197 ID - Richon2000 ER - TY - JOUR AU - Kwon, H. J. AU - Kim, M. S. AU - Kim, M. J. AU - Nakajima, H. AU - Kim, K. W. PY - 2002 DA - 2002// TI - Histone deacetylase inhibitor FK228 inhibits tumor angiogenesis JO - Int J Cancer VL - 97 UR - https://doi.org/10.1002/ijc.1602 DO - 10.1002/ijc.1602 ID - Kwon2002 ER - TY - JOUR AU - Kim, M. S. AU - Kwon, H. J. AU - Lee, Y. M. AU - Baek, J. H. AU - Jang, J. E. AU - Lee, S. W. AU - Moon, E. J. AU - Kim, H. S. AU - Lee, S. K. AU - Chung, H. Y. AU - Kim, C. W. AU - Kim, K. W. PY - 2001 DA - 2001// TI - Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes JO - Nat Med VL - 7 UR - https://doi.org/10.1038/86507 DO - 10.1038/86507 ID - Kim2001 ER - TY - JOUR AU - Sasakawa, Y. AU - Naoe, Y. AU - Noto, T. AU - Inoue, T. AU - Sasakawa, T. AU - Matsuo, M. AU - Manda, T. AU - Mutoh, S. PY - 2003 DA - 2003// TI - Antitumor efficacy of FK228, a novel histone deacetylase inhibitor, depends on the effect on expression of angiogenesis factors JO - Biochem Pharmacol VL - 66 UR - https://doi.org/10.1016/S0006-2952(03)00411-8 DO - 10.1016/S0006-2952(03)00411-8 ID - Sasakawa2003 ER - TY - JOUR AU - Slaton, J. W. AU - Karashima, T. AU - Perrotte, P. AU - Inoue, K. AU - Kim, S. J. AU - Izawa, J. AU - Kedar, D. AU - McConkey, D. J. AU - Millikan, R. AU - Sweeney, P. AU - Yoshikawa, C. AU - Shuin, T. AU - Dinney, C. P. PY - 2001 DA - 2001// TI - Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder JO - Clin Cancer Res VL - 7 ID - Slaton2001 ER - TY - JOUR AU - Hansford, L. M. AU - Thomas, W. D. AU - Keating, J. M. AU - Burkhart, C. A. AU - Peaston, A. E. AU - Norris, M. D. AU - Haber, M. AU - Armati, P. J. AU - Weiss, W. A. AU - Marshall, G. M. PY - 2004 DA - 2004// TI - Mechanisms of embryonal tumor initiation: distinct roles for MycN expression and MYCN amplification JO - Proc Natl Acad Sci U S A VL - 101 UR - https://doi.org/10.1073/pnas.0401083101 DO - 10.1073/pnas.0401083101 ID - Hansford2004 ER - TY - JOUR AU - Detjen, K. M. AU - Murphy, D. AU - Welzel, M. AU - Farwig, K. AU - Wiedenmann, B. AU - Rosewicz, S. PY - 2003 DA - 2003// TI - Downregulation of p21(waf/cip-1) mediates apoptosis of human hepatocellular carcinoma cells in response to interferon-gamma JO - Exp Cell Res VL - 282 UR - https://doi.org/10.1016/S0014-4827(02)00011-3 DO - 10.1016/S0014-4827(02)00011-3 ID - Detjen2003 ER - TY - JOUR AU - Burgess, A. J. AU - Pavey, S. AU - Warrener, R. AU - Hunter, L. J. AU - Piva, T. J. AU - Musgrove, E. A. AU - Saunders, N. AU - Parsons, P. G. AU - Gabrielli, B. G. PY - 2001 DA - 2001// TI - Up-regulation of p21(WAF1/CIP1) by histone deacetylase inhibitors reduces their cytotoxicity JO - Mol Pharmacol VL - 60 ID - Burgess2001 ER - TY - JOUR AU - Nguyen, D. M. AU - Schrump, W. D. AU - Chen, G. A. AU - Tsai, W. AU - Nguyen, P. AU - Trepel, J. B. AU - Schrump, D. S. PY - 2004 DA - 2004// TI - Abrogation of p21 expression by flavopiridol enhances depsipeptide-mediated apoptosis in malignant pleural mesothelioma cells JO - Clin Cancer Res VL - 10 UR - https://doi.org/10.1158/1078-0432.CCR-0901-3 DO - 10.1158/1078-0432.CCR-0901-3 ID - Nguyen2004 ER - TY - JOUR AU - Rosato, R. R. AU - Almenara, J. A. AU - Yu, C. AU - Grant, S. PY - 2004 DA - 2004// TI - Evidence of a functional role for p21WAF1/CIP1 down-regulation in synergistic antileukemic interactions between the histone deacetylase inhibitor sodium butyrate and flavopiridol JO - Mol Pharmacol VL - 65 UR - https://doi.org/10.1124/mol.65.3.571 DO - 10.1124/mol.65.3.571 ID - Rosato2004 ER - TY - JOUR AU - Qiu, L. AU - Burgess, A. AU - Fairlie, D. P. AU - Leonard, H. AU - Parsons, P. G. AU - Gabrielli, B. G. PY - 2000 DA - 2000// TI - Histone deacetylase inhibitors trigger a G2 checkpoint in normal cells that is defective in tumor cells JO - Mol Biol Cell VL - 11 UR - https://doi.org/10.1091/mbc.11.6.2069 DO - 10.1091/mbc.11.6.2069 ID - Qiu2000 ER - TY - JOUR AU - Ungerstedt, J. S. AU - Sowa, Y. AU - Xu, W. S. AU - Shao, Y. AU - Dokmanovic, M. AU - Perez, G. AU - Ngo, L. AU - Holmgren, A. AU - Jiang, X. AU - Marks, P. A. PY - 2005 DA - 2005// TI - Role of thioredoxin in the response of normal and transformed cells to histone deacetylase inhibitors JO - Proc Natl Acad Sci U S A VL - 102 UR - https://doi.org/10.1073/pnas.0408732102 DO - 10.1073/pnas.0408732102 ID - Ungerstedt2005 ER - TY - JOUR AU - Mayo, M. W. AU - Denlinger, C. E. AU - Broad, R. M. AU - Yeung, F. AU - Reilly, E. T. AU - Shi, Y. AU - Jones, D. R. PY - 2003 DA - 2003// TI - Ineffectiveness of histone deacetylase inhibitors to induce apoptosis involves the transcriptional activation of NF-kappa B through the Akt pathway JO - J Biol Chem VL - 278 UR - https://doi.org/10.1074/jbc.M211695200 DO - 10.1074/jbc.M211695200 ID - Mayo2003 ER - TY - JOUR AU - Qian, D. Z. AU - Wang, X. AU - Kachhap, S. K. AU - Kato, Y. AU - Wei, Y. AU - Zhang, L. AU - Atadja, P. AU - Pili, R. PY - 2004 DA - 2004// TI - The histone deacetylase inhibitor NVP-LAQ824 inhibits angiogenesis and has a greater antitumor effect in combination with the vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584 JO - Cancer Res VL - 64 UR - https://doi.org/10.1158/0008-5472.CAN-04-0540 DO - 10.1158/0008-5472.CAN-04-0540 ID - Qian2004 ER - TY - JOUR AU - Ozawa, S. AU - Shinohara, H. AU - Kanayama, H. O. AU - Bruns, C. J. AU - Bucana, C. D. AU - Ellis, L. M. AU - Davis, D. W. AU - Fidler, I. J. PY - 2001 DA - 2001// TI - Suppression of angiogenesis and therapy of human colon cancer liver metastasis by systemic administration of interferon-alpha JO - Neoplasia VL - 3 UR - https://doi.org/10.1038/sj.neo.7900128 DO - 10.1038/sj.neo.7900128 ID - Ozawa2001 ER - TY - JOUR AU - Liu, T. AU - Bohlken, A. AU - Kuljaca, S. AU - Lee, M. AU - Nguyen, T. AU - Smith, S. AU - Cheung, B. AU - Norris, M. D. AU - Haber, M. AU - Holloway, A. J. AU - Bowtell, D. D. AU - Marshall, G. M. PY - 2005 DA - 2005// TI - The retinoid anticancer signal: mechanisms of target gene regulation JO - Br J Cancer VL - 93 UR - https://doi.org/10.1038/sj.bjc.6602700 DO - 10.1038/sj.bjc.6602700 ID - Liu2005 ER - TY - JOUR AU - Qian, D. Z. AU - Kato, Y. AU - Shabbeer, S. AU - Wei, Y. AU - Verheul, H. M. AU - Salumbides, B. AU - Sanni, T. AU - Atadja, P. AU - Pili, R. PY - 2006 DA - 2006// TI - Targeting tumor angiogenesis with histone deacetylase inhibitors: the hydroxamic acid derivative LBH589 JO - Clin Cancer Res VL - 12 UR - https://doi.org/10.1158/1078-0432.CCR-05-1132 DO - 10.1158/1078-0432.CCR-05-1132 ID - Qian2006 ER -